StockData
Profusa, Inc. logo

Profusa, Inc. (PFSA) stock

PFSANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NVACW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.35+0.01 (+1.84%)

Close on Nov 18, 2026Market cap $46.89KP/E –Yield –

Profusa operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Profusa's operating income for the twelve months ending Jun 30, 2026 was -$31.83M. For fiscal 2025 it was -$27.71M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$27.71M–
FY2024Dec 31, 2024-$4.50M–
FY2023Dec 31, 2023-$1.51M–
FY2022Dec 31, 2022-$1.27M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.55M–
Q1 FY2026Mar 31, 2026-$4.01M–
Q4 FY2025Dec 31, 2025-$3.57M–
Q3 FY2025Sep 30, 2025-$21.71M–
Q2 FY2025Jun 30, 2025-$1.00M–
Q1 FY2025Mar 31, 2025-$1.42M–
Q4 FY2024Dec 31, 2024-$1.08M–
Q3 FY2024Sep 30, 2024-$1.10M–
Q2 FY2024Jun 30, 2024-$253.13K–
Q1 FY2024Mar 31, 2024-$470.84K–
Q4 FY2023Dec 31, 2023-$460.16K–
Q3 FY2023Sep 30, 2023-$290.10K–
Q2 FY2023Jun 30, 2023-$314.71K–
Q1 FY2023Mar 31, 2023-$443.72K–
Q4 FY2022Dec 31, 2022-$407.01K–
Q3 FY2022Sep 30, 2022-$404.43K–
Q2 FY2022Jun 30, 2022-$217.53K–
Q1 FY2022Mar 31, 2022-$241.60K–

More Profusa figures

See a number that looks wrong?